| Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis (NCT00648141) | Pfizer | 2003-01-01 |
| A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea (NCT00650637) | Pfizer | 2003-01-01 |
| An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia (NCT00648726) | Pfizer | 2003-01-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults (NCT00644293) | Pfizer | 2003-01-01 |
| Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose (NCT00150410) | Pfizer | 2003-01-01 |
| CPG 7909 in Patients With Cutaneous T-Cell Lymphoma (NCT00043420) | Pfizer | 2003-01-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis (NCT00644449) | Pfizer | 2003-01-01 |
| A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea (NCT00649415) | Pfizer | 2003-01-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients (NCT00643227) | Pfizer | 2003-01-01 |
| Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens (NCT00052117) | Pfizer | 2003-01-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults (NCT00643409) | Pfizer | 2003-01-01 |
| Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery (NCT00653354) | Pfizer | 2002-12-01 |
| A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer (NCT00051051) | Pfizer | 2002-12-01 |
| A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension (NCT00651287) | Pfizer | 2002-12-01 |
| PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients (NCT00174356) | Pfizer | 2002-12-01 |
| Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat (NCT00643539) | Pfizer | 2002-12-01 |
| A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle (NCT00671320) | Pfizer | 2002-12-01 |
| Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee (NCT00137410) | Pfizer | 2002-11-01 |
| First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors (NCT01469052) | Pfizer | 2002-11-01 |
| Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma (NCT00635323) | Pfizer | 2002-11-01 |
| A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury (NCT00638053) | Pfizer | 2002-11-01 |
| Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis (NCT01736696) | Pfizer | 2002-11-01 |
| A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures (NCT00643136) | Pfizer | 2002-11-01 |
| A Study Of Diflucan In Children With Ringworm Of The Scalp (NCT00645242) | Pfizer | 2002-11-01 |
| A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS (NCT00627003) | Pfizer | 2002-11-01 |
| A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain (NCT00661635) | Pfizer | 2002-11-01 |
| Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus (NCT00572559) | Pfizer | 2002-11-01 |
| Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain (NCT00649610) | Pfizer | 2002-11-01 |
| A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis (NCT00649831) | Pfizer | 2002-10-01 |
| Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery (NCT00683137) | Pfizer | 2002-10-01 |
| A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes (NCT00630851) | Pfizer | 2002-10-01 |
| A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA (NCT00652925) | Pfizer | 2002-10-01 |
| Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (NCT01859949) | Pfizer | 2002-10-01 |
| Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years (NCT00161863) | Pfizer | 2002-09-01 |
| CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer (NCT00043394) | Pfizer | 2002-09-01 |
| Parecoxib In Post Surgery (Hemicolectomy) Pain (NCT00139607) | Pfizer | 2002-09-01 |
| Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). (NCT00140036) | Pfizer | 2002-09-01 |
| A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis (NCT02528201) | Pfizer | 2002-09-01 |
| PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) (NCT00043368) | Pfizer | 2002-09-01 |
| The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) (NCT00041704) | Pfizer | 2002-08-01 |
| Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen (NCT00051844) | Pfizer | 2002-08-01 |
| To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. (NCT00141375) | Pfizer | 2002-08-01 |
| Treatment of Pediatric Hypertension With Altace Trial (NCT00044265) | Pfizer | 2002-07-01 |
| Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support (NCT00050401) | Pfizer | 2002-07-01 |
| Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients (NCT01227395) | Pfizer | 2002-07-01 |
| Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women (NCT00040014) | Pfizer | 2002-06-01 |
| Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer (NCT00143455) | Pfizer | 2002-06-01 |
| Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes (NCT00136916) | Pfizer | 2002-06-01 |
| FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years (NCT00161876) | Pfizer | 2002-05-01 |
| Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes (NCT00137046) | Pfizer | 2002-05-01 |
| A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). (NCT00037206) | Pfizer | 2002-05-01 |
| A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy (NCT00074854) | Pfizer | 2002-05-01 |
| Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents (NCT00156143) | Pfizer | 2002-04-01 |
| Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria (NCT00037050) | Pfizer | 2002-04-01 |
| Parecoxib in Renal Colic (NCT00139646) | Pfizer | 2002-04-01 |
| For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy (NCT00037180) | Pfizer | 2002-04-01 |
| Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants (NCT00161928) | Pfizer | 2002-04-01 |
| CPG 7909 in Patients Wih Stage IV Renal Cell Cancer (NCT00043407) | Pfizer | 2002-03-01 |
| Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. (NCT00150293) | Pfizer | 2002-03-01 |
| Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. (NCT00161772) | Pfizer | 2002-03-01 |
| Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy (NCT00174291) | Pfizer | 2002-03-01 |
| New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) (NCT00035854) | Pfizer | 2002-02-01 |
| FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years (NCT00161889) | Pfizer | 2002-02-01 |
| Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis (NCT00318994) | Pfizer | 2002-02-01 |
| A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension (NCT00150267) | Pfizer | 2002-02-01 |
| FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years (NCT00161850) | Pfizer | 2002-02-01 |
| To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. (NCT00150436) | Pfizer | 2002-02-01 |
| Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) (NCT00418171) | Pfizer | 2002-02-01 |
| Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. (NCT00140062) | Pfizer | 2002-02-01 |
| A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer (NCT00034827) | Pfizer | 2002-01-01 |
| Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients. (NCT00318552) | Pfizer | 2002-01-01 |
| Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer (NCT00279448) | Pfizer | 2002-01-01 |
| Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen (NCT00038103) | Pfizer | 2002-01-01 |
| Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women (NCT00205777) | Pfizer | 2001-12-01 |
| Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer (NCT00143403) | Pfizer | 2001-12-01 |
| Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. (NCT00036218) | Pfizer | 2001-12-01 |
| New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) (NCT00035269) | Pfizer | 2001-12-01 |
| 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation (NCT00150228) | Pfizer | 2001-12-01 |
| Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients (NCT00174343) | Pfizer | 2001-11-01 |
| Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer (NCT01237327) | Pfizer | 2001-11-01 |
| Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection (NCT00035425) | Pfizer | 2001-11-01 |
| Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer (NCT00031278) | Pfizer | 2001-10-01 |
| Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR (NCT00161824) | Pfizer | 2001-10-01 |
| Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain. (NCT00141362) | Pfizer | 2001-10-01 |
| Pregabalin Open-Label Extension Trial in Patients With Partial Seizures (NCT00143143) | Pfizer | 2001-09-01 |
| Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. (NCT00161798) | Pfizer | 2001-09-01 |
| 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation. (NCT00150254) | Pfizer | 2001-09-01 |
| Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane (NCT00036270) | Pfizer | 2001-08-01 |
| The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. (NCT00037219) | Pfizer | 2001-08-01 |
| Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height (NCT00174421) | Pfizer | 2001-04-01 |
| IGF1 Generation Test (NCT00145457) | Pfizer | 2001-04-01 |
| Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) (NCT00141193) | Pfizer | 2001-02-01 |
| Complicated Skin and Skin Structure Infections (NCT00619710) | Pfizer | 2001-02-01 |
| To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy. (NCT00150423) | Pfizer | 2001-01-01 |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer (NCT00026273) | Pfizer | 2001-01-01 |
| Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia (NCT00035347) | Pfizer | 2001-01-01 |
| Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders. (NCT00150449) | Pfizer | 2001-01-01 |
| S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation (NCT00244426) | Pfizer | 2000-12-01 |
| Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer (NCT00140075) | Pfizer | 2000-11-01 |
| Chemoprevention of Oral Premalignant Lesions (NCT00036283) | Pfizer | 2000-11-01 |